Morgan Stanley’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $489K | Sell |
|
|||||
|
2025
Q1 | $884K | Buy |
|
|||||
|
2024
Q4 | $659K | Buy |
|
|||||
|
2024
Q3 | $977K | Buy |
|
|||||
|
2024
Q2 | $389K | Buy |
|
|||||
|
2024
Q1 | $359K | Sell |
|
|||||
|
2023
Q4 | $512K | Buy |
|
|||||
|
2023
Q3 | $96.1K | Sell |
|
|||||
|
2023
Q2 | $101K | Sell |
|
|||||
|
2023
Q1 | $292K | Sell |
|
|||||
|
2022
Q4 | $2.23M | Buy |
|
|||||
|
2022
Q3 | $1.7M | Buy |
|
|||||
|
2022
Q2 | $1.04M | Sell |
|
|||||
|
2022
Q1 | $2.15M | Buy |
|
|||||
|
2021
Q4 | $127K | Sell |
|
|||||
|
2021
Q3 | $404K | Buy |
|
|||||
|
2021
Q2 | $339K | Buy |
|
|||||
|
2021
Q1 | $382K | Sell |
|
|||||
|
2020
Q4 | $708K | Sell |
|
|||||
|
2020
Q3 | $816K | Buy |
|
|||||
|
2020
Q2 | $459K | Sell |
|
|||||
|
2020
Q1 | $1.3M | Sell |
|
|||||
|
2019
Q4 | $1.89M | Sell |
|
|||||
|
2019
Q3 | $1.27M | Buy |
|
|||||
|
2019
Q2 | $220K | Buy |
|
|||||
|
2019
Q1 | $202K | Sell |
|
|||||
|
2018
Q4 | $1.21M | Buy |
|
|||||
|
2018
Q3 | $589K | Buy |
|
|||||
|
2018
Q2 | $508K | Buy |
|
|||||
|
2018
Q1 | $238K | Buy |
|
|||||
|
2017
Q4 | $18K | Buy |
|
|||||
|
2017
Q3 | $5K | Sell |
|
|||||
|
2017
Q2 | $139K | Buy |
|
|||||
|
2017
Q1 | $182K | Sell |
|
|||||
|
2016
Q4 | $327K | Buy |
|
|||||
|
2016
Q3 | $107K | Sell |
|
|||||
|
2016
Q2 | $670K | Buy |
|
|||||
|
2016
Q1 | $507K | Sell |
|
|||||
|
2015
Q4 | $768K | Buy |
|
|||||
|
2015
Q3 | $1.47M | Buy |
|
|||||
|
2015
Q2 | $608K | Buy |
|
|||||
|
2015
Q1 | $288K | Buy |
|
|||||
|
2014
Q4 | $37K | Sell |
|
|||||
|
2014
Q3 | $1.23M | Buy |
|